Skip to main content
. 2022 Dec 7;17(12):e0277984. doi: 10.1371/journal.pone.0277984

Fig 1. Development of symptom status.

Fig 1

Symptom status of all 60 athletes at t0 (first examination date) and t1 (3.3 ± 0.5 months post first examination). 35 of 44 athletes, who had persistent symptoms at t0 still stated persistent symptoms at t1 (progression group PS-PS). Nine athletes became symptom-free over three months (progression group PS-SF). 14 of the 16 athletes remained symptom-free over the observation period (SF-SF). Two athletes developed symptoms over time. Data were collected with medical history and the International Consensus CFS questionnaire [24].